MedPath

重庆三峡云海药业股份有限公司

Ownership
-
Established
2003-12-15
Employees
-
Market Cap
-
Website
https://www.cqsxyhyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

羊藿三七胶囊

Approval Number
国药准字Z20090102
Approval Date
Jan 25, 2024
NMPA

小儿清热止咳口服液

Approval Number
国药准字Z20093102
Approval Date
Jan 25, 2024
NMPA

穿黄清热胶囊

Approval Number
国药准字Z20090593
Approval Date
Jan 25, 2024
NMPA

百癣夏塔热胶囊

Approval Number
国药准字Z20070016
Approval Date
Jun 1, 2022
NMPA

藿香正气水

Approval Number
国药准字Z50020252
Approval Date
Jul 25, 2020
NMPA

还少胶囊

Approval Number
国药准字Z50020249
Approval Date
May 10, 2020
NMPA

复方板蓝根颗粒

Approval Number
国药准字Z50020248
Approval Date
May 10, 2020
NMPA

玄麦甘桔颗粒

Approval Number
国药准字Z50020251
Approval Date
May 10, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H50020476
Approval Date
May 10, 2020
NMPA

消栓口服液

Approval Number
国药准字Z50020250
Approval Date
May 10, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.